Background: Pleural effusion is rare and includes several disease entities in the neonatal period. The aim of this study was to investigate the etiology, management, and outcome of neonatal pleural effusions. Methods: We retrospectively collected all neonates who were admitted to the neonatal intensive care unit of Chung Shan Medical University Hospital, Taichung, Taiwan, with discharge diagnosis of pleural effusion, chylothorax, hydrothorax, hemothorax, and empyema, from January 1999 to December 2009. The characteristics, etiology, management, and outcome were analyzed. Results: There were 21 patients identified, 16 males (76%) and 5 females (24%). Eight patients (38%) had primary and 13 patients (62%) had secondary etiologies. The etiologies included four parapneumonic effusions or empyema (19%); nine chylothorax (42.8%) with four congenital and five iatrogenic after thoracic surgery; three percutaneously inserted central venous catheter extravasation (14%); one umbilical venous catheter extravasation (4.7%); three hydrops fetalis (14%); and one congestive heart failure (4.7%). Fifteen patients (71%) needed chest tube placement. Conservative management with complete cessation of enteral feedings and use of total parenteral nutrition followed with infant formula containing medium-chain triglyceride was successful in six of the patients (67%) with chylothorax. There were two patients (22%) with chylothorax who received somatostatin administration; one was successful and the other one failed. Thoracic duct ligation was performed uneventfully in two patients with acquired chylothorax. There were three mortalities (14.3%) in this study, which were related to causes other than pleural effusion. Conclusions: Pleural effusions in the neonatal stage may result from chylothorax, hydrops fetalis, extravasation of percutaneously inserted central venous catheter, parapneumonic effusion, congestive heart failure, or other less frequently occurring conditions. Diagnostic chest tap is required for subsequent management. Good outcome is the rule except in hydrops fetalis, which carries high mortality rate.
Introduction
Pleural effusion is defined as fluid accumulation in the pleural space, which exists between the parietal pleura of the chest wall and the visceral pleura of the lung. Both layers filter into the space fluid that has been reabsorbed from the lymphatics. Any change of the pulmonary venous hydrostatic pressure, lymphatic pressure, blood oncotic pressure, and local tissue trauma or inflammation will lead to pleural effusion. 1 It is not surprising that so many disorders account for the formation of neonatal pleural effusion. In the literature, causes, such as parapneumonic effusion, empyema, chylothorax, hydrothorax, hemothorax, leakage of central-line fluid, or parenteral nutrition, have been reported. 2 The incidence is rare, ranging from 5.5 per 10,000 to 2.2%. 2, 3 Pleural effusion may occur at any time during the neonatal period, at birth, or antenatally, diagnosed by ultrasound. It may be asymptomatic or result in respiratory distress. Chest radiography and ultrasound are helpful in pleural fluid recognition. Precise diagnosis of the etiology is important for subsequent management. Therefore, thoracentesis or thoracostomy for pleural fluid analysis is mandatory. The aim of this study was to investigate the etiology, management, and outcome of neonatal pleural effusions in one tertiary neonatal care center.
Methods
We retrospectively searched from the hospital computer database for discharge diagnosis of pleural effusion, chylothorax, hydrothorax, hydrops fetalis, hemothorax, and empyema from January 1, 1999, to December 31, 2009. All neonates who were admitted to the neonatal intensive care unit (NICU) of Chung Shan Medical University Hospital, Taichung, Taiwan, and had the above diagnosis, were included. All patients with pleural effusion were diagnosed by chest radiography. Chest echography was performed for most patients to calculate the volume and for subsequent follow-up. Thoracentesis was performed for pleural fluid analysis. Chest tube was inserted if there was persistent respiratory distress after thoracentesis. The volume of drained fluid was recorded by total volume per kilogram in the first day of drainage. The diagnostic criteria for chylothorax in our NICU were according to the proposal of Bϋttiker et al 4 : total white cell count 1000/mL, with a lymphocyte fraction > 80% and triglyceride levels > 110 mg/dL. Hydrops fetalis was defined as excess fluid accumulation in the fetus and had characteristic findings, such as skin edema, pleural effusion, pericardial effusion, ascites, and polyhydramnios. Hemothorax meant the presence of blood in the pleural space. Empyema was defined as positive pleural effusion culture or purulent pleural effusion with elevated white blood cell count and a higher percentage of polymorphonuclear cells (PMNs). The presence of high level of glucose and triglyceride content with low cell count in the pleural effusion suggested the extravasation of parenteral nutrition from central venous catheter.
Clinical information of sex, gestational age, birth weight, age, delivery method, unilateral or bilateral, prenatal diagnosis, clinical presentation, laboratory data of pleural effusion, duration and volume of pleural effusion, associated diseases, diagnosis, management, length of each therapeutic modality, morbidity, and mortality were obtained from the charts. Pleural effusion data include the appearance, pH, density, red blood cell count, white blood cell count with differential count, percentage of lymphocytes, percentage of PMNs, protein, glucose, lactate dehydrogenase, cholesterol, and triglyceride. Data were expressed as median (range) and number (percentage). Descriptive analysis with SPSS version 16.0 software package was carried out.
Results
There were 21 patients identified, 16 males (76%) and 5 females (24%). The median gestational age was 32 weeks (range, 25e39 weeks). There were 7 full-term babies and 14 premature babies. The birth weight ranged from 780 g to 3110 g. There were 3 twins and 18 singletons. Cesarean delivery was the mode of delivery performed in 16 patients and vaginal delivery in 5. The site of occurrence was unilateral in 14 patients (6 in the right and 8 in the left) and bilateral in 6 patients. The site of occurrence was not recorded in one patient with acquired chylothorax after thoracic surgery. Prenatal diagnosis was made in two patients; one had hydrops fetalis and the other had congenital chylothorax.
Etiologies and initial clinical presentation
The etiologies of our neonates with pleural effusion and the percentage of each category are listed in Table 1 . Eight patients (38%) were primary and 13 patients (62%) were secondary. Secondary etiologies were more frequent than primary etiologies. Chylothorax was the most common etiology with nine patients (42.8%), and acquired chylothorax was slightly predominant. The initial clinical presentations were acute onset of dyspnea and hypoxia. All five cases with iatrogenic chylothorax occurred after thoracic surgery; their clinical information is summarized in Table 2 .
Characteristics, associated diseases, management, and outcome
Laboratory data, duration, volume, management, and mortality of pleural effusions are summarized in Table 3 . One patient who suffered from acquired chylothorax after Blalock-Taussig shunt for tetralogy of Fallot had effusion duration of 34 days. She did not respond to medium-chain triglyceride formula and somatostatin administration; hence, thoracic duct ligation was performed. Fifteen patients (71%) needed chest tube placement. One patient with congenital chylothorax had a resolution of pleural effusion after complete cessation of enteral feedings and institution of total parenteral nutrition (TPN) followed by medium-chain triglyceride formula without chest tube placement. Another one with congenital chylothorax did not respond to complete cessation of enteral feedings but was successfully treated by octreotide.
One patient with hydrops fetalis, congenital anomaly, and congenital heart disease, who received aggressive resuscitation immediately after delivery but died 6 hours later, did not have chest tube insertion, either. The pleural effusion of the other two patients with hydrops fetalis resolved after thoracostomy. The drained volume was greatest in the hydrops fetalis group at 225.6 mL/kg/d. All four patients with parapneumonic effusion or empyema were treated conservatively and successfully with parenteral antibiotics. Urokinase or video-assisted thoracoscopy was not used.
Even with the same etiologies and management protocol, the duration of effusion was variable. In the central venous extravasation group, central lines were removed after diagnosis, and the median duration of effusions was 2.5 days (range, 2e4 days). The patients in this group had the fastest resolution of pleural effusion. One patient had a second episode of pleural effusion with cardiac tamponade, which resolved after pericardiocentesis. She was subsequently diagnosed with a double superior vena cava associated with venous thrombosis in the left brachiocephalic vein and left superior vena cava. Another patient had fungemia. Candida parapsilosis was found in the cultures taken from the blood, urine, pleural effusion, and the percutaneously inserted central venous catheter (PICC) tip of this patient.
Two patients with congenital chylothorax had special associated diseases. One patient who had floppy baby syndrome was presented immediately after delivery. The muscle biopsy revealed myotubular myopathy. Another patient had carotid venous malformation and received a prolonged course of treatment. The causes for the three cases of hydrops fetalis were idiopathic in one and congenital heart disease in the other two.
There were three mortalities (14.3%) in this series. Two patients with hydrops fetalis and congenital heart anomaly died because of cardiopulmonary failure. One in the extravasation of TPN group died because of perforated necrotizing enterocolitis. There was no mortality directly related to pleural effusion.
Discussion
In the retrospective study by Rocha et al, 2 62 neonates were identified over an 8-year period in the NICU of six medical centers in the north of Portugal. Pleural effusions were congenital in 32% and acquired in 68%. The disease category distribution was similar to that in our study. Less frequently occurring conditions included twin-to-twin transfusion, Escherichia coli infection, meconium peritonitis with hypoproteinemia, superior vena cava syndrome, hypoproteinemia, and nephrotic syndrome with renal BT shunt Z Blalock-Taussig shunt; CoA Z coarctation of the aorta; DAA Z double aortic arch; DORV Z double-outlet right ventricle; IAA Z interrupted aortic arch; L-TGA Z L-transposition of the great arteries; MCT Z medium-chain triglyceride; PA Z pulmonary atresia; PDA Z patent ductus arteriosus; PS Z pulmonary stenosis; TOF Z tetralogy of Fallot; VSD Z ventricular septal defect.
failure. The investigators had five mortalities because of pulmonary hypoplasia. 2 Chylothorax was the most common cause of neonatal pleural effusion (9 of 21, 43%) in our study. Congenital chylothorax accounted for 44% and postoperative chylothorax for 56% of cases. The range of age of occurrence of nonacquired chylothorax was 5e46 days and was 2e44 days for postoperative chylothorax. In Rocha et al's 2 report, congenital chylothorax was associated with hydrops fetalis in one-third of the cases and had mainly bilateral involvement. There was no such association found in our study.
Bϋttiker et al 4 established the criteria for chylothorax: total white cell count 1000 cells/mL with a lymphocyte fraction > 80% and triglycerides > 110 mg/dL. One of our patients with gestational age of 26 weeks and diagnosed with chylothorax at 46 days of age had lymphocyte fraction of 66% with 34% PMNs. There may have been concomitant infection or possible irritation of the pleura that resulted in higher PMN counts.
The disease associations of congenital chylothorax found in our study were myotubular myopathy (n Z 1) and carotid arteriovenous malformation (n Z 1). Myotubular myopathy association was also reported by Smets. 5 He reported a newborn baby with X-linked myotubular myopathy who developed a clinically relevant chylothorax in his second week of life, which required drainage and treatment with octreotide acetate. Other associations with chromosome anomalies, such as Turner syndrome, Noonan syndrome, and Down syndrome with generalized lymphangiomatosis, were also reported.
Complete cessation of enteral feedings and use of TPN or formula that contains medium-chain triglyceride reduce the chyle flow and can lead to closure of the thoracic duct spontaneously. This treatment was successful in six of nine (67%) of our patients. However, the loss of protein, lymphocyte, and humoral antibodies leads to an immunocompromised state, which may precipitate to infection throughout the course.
The successful use of continuous administration of octreotide (a long-acting somatostatin analog) has been reported in several small series. The dosage of octreotide used varied between 0.3 mg/kg/h and 40 mg/kg/h. The chyle that drained was reduced within 1e2 days. The chest tube can often be removed within 1 week, but some would be delayed up to 2 weeks. 6 We only had experience with two patients, both of whom showed slow improvement after octreotide administration without any side effect. The reasons for the slow improvement could be high central venous pressure or severe thoracic duct injury after thoracic surgery. Somatostatin and octreotide are generally safe. Adverse reactions include cramp, nausea, diarrhea, fatty stool, flatulence, liver dysfunction, hyperglycemia, hypothyroidism, and necrotizing enterocolitis. Values are expressed as median (range) or n (%). CHF Z congestive heart failure; TPN Z total parenteral nutrition.
Surgical intervention for pleural effusion, such as thoracic duct ligation, pleuroperitoneal shunts, or pleurodesis, is recommended after medical therapy fails. 7 Two of our patients in the postoperative chylothorax group had uneventful thoracic duct ligations.
PICC is widely used in NICU worldwide for administering TPN to premature babies. Several complications have been reported, including pericardial effusion with or without cardiac tamponade, pleural effusion, ascites, venous thrombosis, catheter removal difficulties, phlebitis, and infection. 8, 9, 10 The prevalence of parenteral fluid extravasation from central venous catheter was 0.05e1.1%. 11 The reported mechanisms include (1) vessel perforation during catheterization; (2) retrograde passage of a central venous catheter into the lymphatic duct; (3) erosion of the vein; and (4) hyperosmotic endothelial damage leading to increased vascular permeability. 12, 13 In our series, all of the tip positions of PICC and umbilical venous catheter were well located in the superior and inferior vena cava. There was no evidence of vessel perforation. The PICC used in our NICU was Bard Per-Q-Cath (Salt lake city, UT, USA), made of silicone-rubber material, and the overall risk of effusion appeared to be small. The presence of high level of glucose and triglyceride content with low cell counts in the drained fluid suggested the extravasation of parenteral nutrition. 14 Hydrops fetalis is a condition of excess fluid accumulation in the fetus. It has several characteristic antenatal ultrasonographic findings, such as skin edema, pleural effusion, pericardial effusion, ascites, and polyhydramnios. Abrams et al 15 reviewed retrospectively a total of 253,651 discharges from 162 NICUs, and hydrops fetalis was found in 598 patients. Congenital heart problems were the most common diagnosis (13.7%). Other causes included abnormalities in heart rate (10.4%), twin-to-twin transfusion (9%), congenital anomalies (8.7%), chromosomal abnormalities (7.5%), congenital viral infections (6.7%), congenital anemia (5%), and congenital chylothorax (3.2%). The survival rate of hydrops fetalis was less than 50%. 16 The causes of hydrops fetalis can be determined antenatally in 50e85% of the cases. 17 Aggressive prenatal intervention improves the survival rate of hydrops fetalis.
Parapneumonic effusions or empyema occur as a complication of bacterial pneumonia. Pathogens reported in the literature include Staphylococcus aureus, group A Streptococcus, Bacteroides fragilis, E coli, Klebsiella, Pseudomonas aeruginosa, and Acinetobacter caloacesticus. 18, 19 However, no pathogen was identified in the pleural fluid or blood from our four patients. This may be the result of the concurrent antibiotics usage. Empyema is defined as pus noted in the pleural fluid, positive culture, or positive Gram's stain. It can be divided into three stages: (1) exudative stage, (2) fibrinopurulent stage, and (3) organizational stage. Chest ultrasound is helpful in the diagnosis of pleural effusion and for monitoring the progression of parapneumonic effusion. Chest drain placement is indicated in cases of enlarging effusion or respiratory compromise. If there is fibrin deposition and peel formation, fibrinolysis with urokinase can shorten the hospital stay. Surgical intervention with thracotomy or videoassisted thoracoscopy is advised if treatment with chest drainage with or without fibrinolysis has failed. 20 Congestive heart failure results in bilateral pleural effusion. Diagnostic thoracentesis is indicated if the effusion is not bilateral or the patient is febrile.
In conclusion, pleural effusion in the neonatal stage may result from chylothorax, hydrops fetalis, extravasation of PICC or umbilical venous catheter, parapneumonic effusion, congestive heart failure, or other less common conditions. Diagnostic chest tap for pleural fluid analysis is essential for subsequent management. Good outcome is the rule except in hydrops fetalis, which carries a high mortality rate.
